RPG Investment Advisory’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-50
Closed -$3K 351
2020
Q2
$3K Hold
50
﹤0.01% 300
2020
Q1
$3K Sell
50
-50
-50% -$3.71K ﹤0.01% 236
2019
Q4
$9K Hold
100
﹤0.01% 188
2019
Q3
$8K Sell
100
-1
-1% -$81 ﹤0.01% 189
2019
Q2
$9K Sell
101
-23
-19% -$2.27K ﹤0.01% 185
2019
Q1
$13K Sell
124
-2
-2% -$199 ﹤0.01% 180
2018
Q4
$11K Hold
126
﹤0.01% 184
2018
Q3
$12K Hold
126
﹤0.01% 204
2018
Q2
$15K Sell
126
-7
-5% -$769 ﹤0.01% 193
2018
Q1
$13K Sell
133
-16,014
-99% -$1.62M ﹤0.01% 261
2017
Q4
$1.69M Sell
16,147
-658
-4% -$72.3K 0.41% 67
2017
Q3
$1.89M Sell
16,805
-359
-2% -$39.1K 0.48% 62
2017
Q2
$1.92M Sell
17,164
-877
-5% -$99.1K 0.53% 59
2017
Q1
$2.1M Buy
18,041
+814
+5% +$90.1K 0.62% 58
2016
Q4
$1.81M Sell
17,227
-2,353
-12% -$246K 0.61% 57
2016
Q3
$2.16M Sell
19,580
-44,898
-70% -$5.95M 0.68% 57
2016
Q2
$9.39M Buy
64,478
+5,645
+10% +$800K 2.51% 3
2016
Q1
$8.43M Sell
58,833
-2,077
-3% -$295K 3.26% 2
2015
Q4
$9.41M Buy
+60,910
New +$8.89M 3.52% 2

Other funds holding TARO

RPG Investment Advisory's TARO Position: Q3 2020 in Review

RPG Investment Advisory sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2020, closing a stake of 50 shares — an estimated $3K sold.

RPG Investment Advisory first reported a position in TARO in Q4 2015 and held it in 19 quarters. The position peaked at $9.41M in Q4 2015. 78 funds tracked by Wall St. Rank hold TARO as of Q3 2020.

  • RPG Investment Advisory reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2020 after selling out during the quarter.
  • RPG Investment Advisory sold 50 Taro Pharmaceutical Industries Ltd. shares in Q3 2020, an estimated $3K.
  • RPG Investment Advisory first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 19 quarters.
  • RPG Investment Advisory's Taro Pharmaceutical Industries Ltd. position peaked at $9.41M in Q4 2015.
  • 78 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2020.

Based on RPG Investment Advisory's 13F filing for Q3 2020, filed 6 Nov 2020.